Blood Test to Predict Radiation Response and Toxicity in Patients Undergoing Radiation Therapy
NCT03142425 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2019-02-07
Summary
Collect blood samples and associated clinical data prior to and post radiation treatment.
Conditions
- Radiation Therapy
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
DxTerity Diagnostics
lead INDUSTRY
Principal Investigators
-
Robert Terbrueggen, PhD · President and CEO
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-06-19
- Primary Completion
- 2019-12-31
- Completion
- 2019-12-31
Countries
- United States
Study Locations
More Related Trials
-
Blood Test for Early Detection of Breast Cancer Using Todos Medical -Breast 1(TM-B1) Assay
NCT03343691 ·Status: UNKNOWN
-
Screening in Myocardial Perfusion Patients
NCT00943241 ·Status: COMPLETED
-
Breath Test for Biomarkers in Humans Receiving Total Body Irradiation
NCT02152722 ·Status: UNKNOWN
-
Metabolomic and Epigenetic Profiling of Bodyfluids From Lung and Brain Cancer Receiving Radiation Therapy
NCT02259218 ·Status: COMPLETED
-
Predictive Blood Tests for Severe Radiation Reactions in Breast Cancer Patients
NCT00652678 ·Status: TERMINATED
-
Praegnant Breast Cancer: Early/Advanced/Metastatic
NCT02338167 ·Status: RECRUITING
-
Radiation-induced Toxicity of the Heart
NCT06986291 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prediction of Appearance of Late Cutaneous Side Effects After RadioTherapy
NCT03060226 ·Status: COMPLETED ·Phase: NA
-
Prophylactic Irradiation to the Contralateral Breast for BCAs Patients
NCT04960839 ·Status: RECRUITING ·Phase: NA
-
HER2 PET Imaging in Breast Cancer Patients Using [68GA]ABY-025
NCT02095210 ·Status: TERMINATED ·Phase: PHASE1
-
A Mammography FastTrack Program in Increasing the Number of Women Undergoing Breast Cancer Screening
NCT00462891 ·Status: COMPLETED ·Phase: NA
-
Detection of Aggressive Breast Tumors Using Tc-99m-NC100692
NCT00888589 ·Status: COMPLETED
-
Comparison of the Breast Tumor Microenvironment
NCT03165487 ·Status: ACTIVE_NOT_RECRUITING
-
Single Dose Ablative Radiation Treatment for Early-Stage Breast Cancer
NCT02316561 ·Status: COMPLETED ·Phase: NA
-
Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification
NCT01839045 ·Status: UNKNOWN
-
Research for Predictive Biologic Parameters of Cutaneous Hypersensitivity After Brachytherapy in Breast Cancer
NCT00922961 ·Status: COMPLETED ·Phase: NA
-
Predictive Role of New Biomarkers for Hypersensitive Patients to Radiation in Breast Cancer (BIORISE)
NCT03252717 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Quantifying Radiation-Induced Skin Reactions: Establishing the Foundation for Future Prediction Models
NCT06029231 ·Status: RECRUITING
-
Prospective Cohort Study of Breast Cancer Patients Treated With Radiotherapy
NCT04203849 ·Status: ENROLLING_BY_INVITATION
-
A Multicenter Breast Cancer Biospecimen Registry
NCT02712645 ·Status: UNKNOWN
-
Age-related Changes in the Immune System and Their Impact on Elderly Breast Cancer
NCT02327572 ·Status: COMPLETED
-
Breast Cancer Lung Late Effects
NCT02725840 ·Status: COMPLETED
-
Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol
NCT02078570 ·Status: UNKNOWN
-
Evaluation of an Apoptotic Test for Predicting Late Toxicities After Radiotherapy in Breast and Prostate Cancer Patients
NCT00893035 ·Status: COMPLETED
-
Genotoxicity Assessment for Patients Undergoing Radiation Treatment
NCT00167427 ·Status: COMPLETED